{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:33:10Z","timestamp":1762432390962,"version":"3.37.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-023-09185-8","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T15:02:19Z","timestamp":1706799739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["WT1 and TP53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia"],"prefix":"10.1007","volume":"51","author":[{"given":"Ali","family":"Asghari-Ghomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faranak","family":"Fallahian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Garavand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"29","key":"9185_CR1","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","volume":"34","author":"C Ganzel","year":"2016","unstructured":"Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta EM et al (2016) Extramedullary Disease in adult acute Myeloid Leukemia is common but lacks Independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980\u20132008. J Clin Oncol 34(29):3544","journal-title":"J Clin Oncol"},{"issue":"4","key":"9185_CR2","first-page":"424","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood the Journal of the American Society of Hematology 129(4):424\u2013447","journal-title":"Blood the Journal of the American Society of Hematology"},{"issue":"12","key":"9185_CR3","first-page":"1627","volume":"129","author":"DA Pollyea","year":"2017","unstructured":"Pollyea DA, Jordan CT (2017) Therapeutic targeting of acute Myeloid Leukemia stem cells. Blood the Journal of the American Society of Hematology 129(12):1627\u20131635","journal-title":"Blood the Journal of the American Society of Hematology"},{"issue":"10147","key":"9185_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE (2018) Acute Myeloid Leukemia. The Lancet 392(10147):593\u2013606","journal-title":"The Lancet"},{"issue":"1","key":"9185_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/ijms20010228","volume":"20","author":"C Rautenberg","year":"2019","unstructured":"Rautenberg C, Germing U, Haas R, Kobbe G, Schroeder T (2019) Relapse of acute Myeloid Leukemia after allogeneic stem cell transplantation: prevention, detection, and treatment. Int J Mol Sci 20(1):228","journal-title":"Int J Mol Sci"},{"issue":"12","key":"9185_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/gcc.22796","volume":"58","author":"K Barbosa","year":"2019","unstructured":"Barbosa K, Li S, Adams PD, Deshpande AJ (2019) The role of TP53 in acute Myeloid Leukemia: challenges and opportunities. Genes Chromosom Cancer 58(12):875\u2013888","journal-title":"Genes Chromosom Cancer"},{"issue":"12","key":"9185_CR7","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3390\/jcm11123306","volume":"11","author":"D Lazzarotto","year":"2022","unstructured":"Lazzarotto D, Candoni A (2022) The role of wilms\u2019 Tumor gene (WT1) expression as a marker of minimal residual Disease in acute Myeloid Leukemia. J Clin Med 11(12):3306","journal-title":"J Clin Med"},{"issue":"4","key":"9185_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/bmt.2011.121","volume":"47","author":"X Zhao","year":"2012","unstructured":"Zhao X, Jin S, Zhu H, Xu L, Liu D, Chen H et al (2012) Wilms\u2019 Tumor gene 1 expression: an Independent acute Leukemia prognostic indicator following allogeneic hematopoietic SCT. Bone Marrow Transplant 47(4):499\u2013507","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"9185_CR9","first-page":"1599","volume":"119","author":"C Schmid","year":"2012","unstructured":"Schmid C, Labopin M, Nagler A, Niederwieser D, Castagna L, Tabrizi R et al (2012) Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Blood the Journal of the American Society of Hematology 119(6):1599\u20131606","journal-title":"Blood the Journal of the American Society of Hematology"},{"issue":"3","key":"9185_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbmt.2014.11.007","volume":"21","author":"N Bejanyan","year":"2015","unstructured":"Bejanyan N, Weisdorf DJ, Logan BR, Wang H-L, Devine SM, de Lima M et al (2015) Survival of patients with acute Myeloid Leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. Biol Blood Marrow Transplant 21(3):454\u2013459","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"9185_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbmt.2014.12.016","volume":"21","author":"T Schroeder","year":"2015","unstructured":"Schroeder T, Rachlis E, Bug G, Stelljes M, Klein S, Steckel NK et al (2015) Treatment of acute Myeloid Leukemia or Myelodysplastic Syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions\u2014a retrospective multicenter analysis from the German Cooperative Transplant Study Group. Biol Blood Marrow Transplant 21(4):653\u2013660","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"9185_CR12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1080\/15384101.2021.1951938","volume":"20","author":"Y Yao","year":"2021","unstructured":"Yao Y, Chai X, Gong C, Zou L (2021) WT1 inhibits AML cell proliferation in a p53-dependent manner. Cell Cycle 20(16):1552\u20131560","journal-title":"Cell Cycle"},{"issue":"1","key":"9185_CR13","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1111\/ctr.12046","volume":"27","author":"V V\u00e1lkov\u00e1","year":"2013","unstructured":"V\u00e1lkov\u00e1 V, Pol\u00e1k J, Markov\u00e1 M, V\u00edtek A, H\u00e1jkov\u00e1 H, \u0160\u00e1lek C et al (2013) Minimal residual Disease detectable by quantitative assessment of WT 1 gene before allogeneic stem cell transplantation in patients in first remission of acute Myeloid Leukemia has an impact on their future prognosis. Clin Transplant 27(1):E21\u2013E9","journal-title":"Clin Transplant"},{"issue":"1","key":"9185_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3892\/etm.2011.363","volume":"3","author":"J Pol\u00e1k","year":"2012","unstructured":"Pol\u00e1k J, H\u00e1jkov\u00e1 H, Maalaufov\u00e1-Soukupov\u00e1 J, Markov\u00e1 J, \u0160\u00e1lek C, Schwarz J et al (2012) Estimation of molecular upper remission limit for monitoring minimal residual Disease in peripheral blood of acute Myeloid Leukemia patients by WT1 expression. Experimental and Therapeutic Medicine 3(1):129\u2013133","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"8","key":"9185_CR15","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/sj.leu.2403809","volume":"19","author":"M Weisser","year":"2005","unstructured":"Weisser M, Kern W, Rauhut S, Schoch C, Hiddemann W, Haferlach T et al (2005) Prognostic impact of RT\u2013PCR-based quantification of WT1 gene expression during MRD monitoring of acute Myeloid Leukemia. Leukemia 19(8):1416\u20131423","journal-title":"Leukemia"},{"issue":"31","key":"9185_CR16","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1200\/JCO.2009.22.4865","volume":"27","author":"D Cilloni","year":"2009","unstructured":"Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV et al (2009) Real-time quantitative polymerase chain reaction detection of minimal residual Disease by standardized WT1 assay to enhance risk stratification in acute Myeloid Leukemia: a European LeukemiaNet study. J Clin Oncol 27(31):5195\u20135201","journal-title":"J Clin Oncol"},{"issue":"11","key":"9185_CR17","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1038\/leu.2013.111","volume":"27","author":"J Nomded\u00e9u","year":"2013","unstructured":"Nomded\u00e9u J, Hoyos M, Carricondo M, Bussaglia E, Estivill C, Esteve J et al (2013) Bone marrow WT1 levels at diagnosis, postinduction and postintensification in adult de novo AML. Leukemia 27(11):2157\u20132164","journal-title":"Leukemia"},{"key":"9185_CR18","first-page":"1149","volume":"93","author":"G Rossi","year":"2014","unstructured":"Rossi G, Minervini MM, Melillo L, Di Nardo F, De Waure C, Scalzulli PR et al (2014) Predictive role of minimal residual Disease and log clearance in acute Myeloid Leukemia: a comparison between multiparameter flow cytometry and Wilm\u2019s Tumor 1 levels. Ann Hematol 93:1149\u20131157","journal-title":"Ann Hematol"},{"issue":"28","key":"9185_CR19","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1200\/JCO.2007.15.2058","volume":"26","author":"P Paschka","year":"2008","unstructured":"Paschka P, Marcucci G, Ruppert AS, Whitman SP, Mr\u00f3zek K, Maharry K et al (2008) Wilms\u2019 Tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute Myeloid Leukemia: a cancer and Leukemia group B study. J Clin Oncol 26(28):4595","journal-title":"J Clin Oncol"},{"issue":"4","key":"9185_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.leukres.2011.09.005","volume":"36","author":"JX Gray","year":"2012","unstructured":"Gray JX, McMillen L, Mollee P, Paul S, Lane S, Bird R et al (2012) WT1 expression as a marker of minimal residual Disease predicts outcome in acute Myeloid Leukemia when measured postconsolidation. Leuk Res 36(4):453\u2013458","journal-title":"Leuk Res"},{"issue":"7","key":"9185_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/petr.12585","volume":"19","author":"K Mattsson","year":"2015","unstructured":"Mattsson K, Honkaniemi E, Barbany G, Gustafsson B (2015) Increased p53 protein expression as a potential predictor of early relapse after hematopoietic stem cell transplantation in children with acute myelogenous Leukemia. Pediatr Transplant 19(7):767\u2013775","journal-title":"Pediatr Transplant"},{"issue":"5","key":"9185_CR22","first-page":"1698","volume":"101","author":"H Ogawa","year":"2003","unstructured":"Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A et al (2003) The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type Leukemia. Blood the Journal of the American Society of Hematology 101(5):1698\u20131704","journal-title":"Blood the Journal of the American Society of Hematology"},{"issue":"1","key":"9185_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/bmt.2014.209","volume":"50","author":"A Israyelyan","year":"2015","unstructured":"Israyelyan A, Goldstein L, Tsai W, Aquino L, Forman SJ, Nakamura R et al (2015) Real-time assessment of relapse risk based on the WT1 marker in acute Leukemia and Myelodysplastic Syndrome patients after hematopoietic cell transplantation. Bone Marrow Transplant 50(1):26\u201333","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"9185_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/bjh.12181","volume":"160","author":"S Pozzi","year":"2013","unstructured":"Pozzi S, Geroldi S, Tedone E, Luchetti S, Grasso R, Colombo N et al (2013) Leukemia relapse after allogeneic transplants for acute Myeloid Leukemia: predictive role of WT 1 expression. Br J Hematol 160(4):503\u2013509","journal-title":"Br J Hematol"},{"issue":"4","key":"9185_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/bmt.2016.318","volume":"52","author":"R Dulery","year":"2017","unstructured":"Dulery R, Nibourel O, Gauthier J, Elsermans V, Behal H, Coiteux V et al (2017) Impact of Wilms\u2019 Tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML. Bone Marrow Transplant 52(4):539\u2013543","journal-title":"Bone Marrow Transplant"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-09185-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:59:10Z","timestamp":1738702750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-09185-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9185"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-09185-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"22 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures and protocols were conducted strictly with the ethical guidelines and standards set forth by the institutional and\/or national research committee. The present study obtained ethical approval from the ethics committee of Shahid Beheshti University of Medical Sciences, with the assigned ethics code number IR.SBMU.RETECH.REC.1401.360.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Before participating in the study, all patients provided informed consent by completing the requisite consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}